Erektil Disfonksiyon Şikayeti ile Üroloji Polikliniğine Başvuran Hastalarda Kardiyovasküler Hastalıkların Değerlendirilmesi
GİRİŞ ve AMAÇ: Erektil disfonskiyon (ED) şikayeti olan hastalarda kardiyovasküler hastalık (KVH) riskinin değerlendirilmesi. YÖNTEM ve GEREÇLER: Aralık 2018 ve Aralık 2019 tarihleri arasında ED sebebi ile başvuran 164 hasta prospektif olarak değerlendirildi. Bilinen KVH’ı olmayan bu hastalara kardiyoloji poliklinik konsültasyonu istendi. Hastaların aydınlatılmış onamı alındıktan sonra tansiyon arteriyel (TA), nabız, elektrokardiyografi (EKG), ekokardiyografi(EKO) bakıldı. Endikasyon dahilinde uygun hastalara koşu bandı egzersiz testi, miyokard perfüzyon sintigrafisi (MPS), koroner angiografi yapıldı BULGULAR: Hastaların %25’inde KVH, %11.6’sında (n=19) angına tespit edildi. Yapılan efor testinde hastaların %9.8’inde (n=16) patolojik bulgular izlendi. Anginası olan ve miyokard perfüzyon sintigrafisi çekilen hastaların %7.3’ünde (n=12) iskemik alanlar izlendi. Hastaların %26.2’sine (n=43) koroner anjiografi yapıldı. Koroner angiografi yapılan hastaların % 30.23’ünde (n=13) korener arterlerde plak formasyonu izlendi. Hastaların %34.88’inde (n=15) left anterior descending (LAD), %11.62’sinde (n=5) right coronary artery (RCA), %4.65’inde (n=2) circumflex arter (Cx), %11.62’sinde (n=5) RCA ve LAD, % 6.97 (n=3) hastada ise LAD ve CX %80’nin üzerinde obstrüksiyon izlendi ve perkütan koroner stent uygulandı. TARTIŞMA ve SONUÇ: ED sebebi ile başvuran hastalar, KVH erken teşhisi ve tedavisi için değerlendirilmelidir.
The Evaluation of Cardiovascular Diseases in Patients Presenting to the Urology Outpatient Clinic with Erectile Dysfunction
INTRODUCTION: To evaluate the risk of cardiovascular disease (CVD) in patients with erectile dysfunction (ED). METHODS: One hundred sixty-four patients presenting due to ED between December 2018 and December 2019 were evaluated prospectively. Cardiology clinic consultations were requested for these patients with no known CVD. Following receipt of informed consent, patients’ arterial blood pressure, heart rate, electrocardiography, and echocardiography were investigated. Suitable patients also underwent the treadmill exercise test, myocardial perfusion scintigraphy, and coronary angiography, as indicated. RESULTS: CVD was detected in 25% of patients, angina being found in 11.6% (n=19). Pathological findings were observed in 9.8% (n=16) of patients at the effort test. Ischemic areas were detected in 7.3% (n=12) of patients with angina and undergoing MPS. Coronary angiography was performed on 26.2% (n=43) of patients. Plaque formation was observed in the coronary arteries of 30.23% (n=13) of patients who underwent coronary angiography. Obstruction was observed in the left anterior descending artery (LAD) in 34.88% (n=15) of patients, in the right coronary artery (RCA) in 11.62% (n=5), in the circumflex artery (Cx) in 4.65% (n=2), in the RCA and LAD in 11.62%, and in the LAD and Cx in 6.97% (n=3), and percutaneous coronary stents were installed. DISCUSSION AND CONCLUSION: Patients presenting with ED must be evaluated for early diagnosis and treatment of CVD.
___
- 1. Gratzke C, Angulo J, Chitaley K, Dai Y-t, Kim NN, Paick J-S, et al. Anatomy, physiology, and pathophysiology of erectile dysfunction. The journal of sexual medicine. 2010; 7: 445-75.
- 2. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993; 270: 83-90.
- 3. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994; 151: 54-61.
- 4. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res. 2000; 12: 305-11.
- 5. Akkus E, Kadioglu A, Esen A, Doran S, Ergen A, Anafarta K, et al. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol 2002; 41: 298-304.
- 6. Besiroglu H, Otunctemur A, Ozbek E. The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. The Journal of Sexual Medicine 2015; 12: 1309-18.
- 7. Jackson G, Montorsi P, Adams MA, Anis T, El-Sakka A, Miner M, et al. Cardiovascular aspects of sexual medicine. The journal of sexual medicine. 2010; 7: 1608-26.
- 8. Glina S, Sharlip ID, Hellstrom WJ. Modifying risk factors to prevent and treat erectile dysfunction. J Sex Med. 2013; 10: 115-9.
- 9. Binmoammar TA, Hassounah S, Alsaad S, Rawaf S, Majeed A. The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: a systematic review. JRSM Open. 2016;7:2054270415622602.
- 10. Taken K, Ekin S, Arısoy A, Günes M, Dönmez M. Erectile dysfunction is a marker for obstructive sleep apnea. Aging Male. 2016; 19: 102-5.
- 11. Farag YMK, Guallar E, Zhao D, Kalyani RR, Blaha MJ, Feldman DI, et al. Vitamin D deficiency is independently associated with greater prevalence of erectile dysfunction: The National Health and Nutrition Examination Survey (NHANES) 2001-2004. Atherosclerosis. 2016; 252: 61-7.
- 12. Persu C, Cauni V, Gutue S, Albu ES, Jinga V, Geavlete P. Diagnosis and treatment of erectile dysfunction-a practical update. J Med Life. 2009; 2: 394-400.
- 13. Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, et al. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med. 2010; 7: 445-75.
- 14. Ma RC, So WY, Yang X, Yu LW, Kong AP, Ko GT, et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 2008; 51: 2045-50.
- 15. Chew KK, Finn J, Stuckey B, Gibson N, Sanfilippo F, Bremner A, et al. Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study. J Sex Med. 2010; 7: 192-202.
- 16. Kirby M, Jackson G, Betteridge J, Friedli K. Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract. 2001; 55: 614-8.
- 17. Jackson G, Boon N, Eardley I, Kirby M, Dean J, Hackett G, et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract. 2010; 64: 848-57.
- 18. Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005; 96: 313-21.
- 19. Vlachopoulos C, Jackson G, Stefanadis C, Montorsi P. Erectile dysfunction in the cardiovascular patient. Eur Heart J. 2013; 34: 2034-46.
- 20. Jackson G, Montorsi P, Adams MA, Anis T, El-Sakka A, Miner M, et al. Cardiovascular aspects of sexual medicine. J Sex Med. 2010; 7: 1608-26.
- 21. Lue TF. Erectile dysfunction. N Engl J Med. 2000; 342: 1802-13.
- 22. Maas R, Schwedhelm E, Albsmeier J, Böger RH. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vascular Medicine. 2002; 7: 213-25.
- 23. Bookstein JJ, Vandeberg J, Machado T. The cavernosal acetylcholine/papaverine response. A practical in vivo method for quantification of endothelium-dependent relaxation. Rationale and experimental validation. Invest Radiol. 1990; 25: 1168-74.
- 24. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet. 1985; 1: 181-4.
- 25. Billups KL, Kaiser DR, Kelly AS, Wetterling RA, Tsai MY, Hanson N, et al. Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Int J Impot Res. 2003; 15: 231-6.
- 26. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol. 2004; 43: 179-84.
- 27. Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes. 2013; 6:99-109.
- 28. Riedner CE, Rhoden EL, Fuchs SC, Wainstein MV, Gonçalves SC, Wainstein RV, et al. Erectile dysfunction and coronary artery disease: an association of higher risk in younger men. J Sex Med. 2011; 8: 1445-53.
- 29. Vlachopoulos C, Rokkas K, Ioakeimidis N, Aggeli C, Michaelides A, Roussakis G, et al. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. European urology. 2005; 48: 996-1003.
- 30. Lütfi T, Küpeli B, Tuncel A, Hasan B, Kordan Y, Deniz N, et al. Erektil Disfonksiyon Kardiyovasküler Hastalığın Erken Habercisi Olabilir mi? Fırat Tıp Dergisi. 2007; 12: 128-31.
- 31. Imprialos K, Koutsampasopoulos K, Manolis A, Doumas M. Erectile dysfunction as a cardiovascular risk factor: time to step up? Curr Vasc Pharmacol. 2021;19(3):301-312.